Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin<scp>FQ</scp>receptor antagonist<scp>NiK</scp>‐21273 in comparison with<scp>SB</scp>‐612111Matteo Marti, Michele Morari, Mirco Budri et al.|British Journal of Pharmacology|2012Cited by 28
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathologyJulia Obergasteiger, Mattia Volta|npj Parkinson s Disease|2023Cited by 25
RIT2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathologyJulia Obergasteiger, Mattia Volta|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2